Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02536950 · ClinicalTrials.gov registry record · NA
An Outpatient Study of Automated Blood Glucose Control With an Insulin-Only Bionic Pancreas
A NA study, sponsored by Bruce A. Buckingham.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT02536950 is a NA study that has completed, run by Bruce A. Buckingham. The registered enrollment target is 16 participants.
The verdict
NCT02536950, a NA study, has completed, sponsored by Bruce A. Buckingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
This is an open-label, non-randomized, pilot study to determine the safety and feasibility of the insulin-only bionic pancreas.
Interventions
- DEVICE Fixed set point
- DEVICE Variable set point
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2015-08 |
| Est. Completion | 2016-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02536950
The ClinicalTrials.gov registry entry for NCT02536950 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bruce A. Buckingham, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Fixed set point is the first listed.
NCT02536950 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02536950 about?
NCT02536950 is a clinical study titled "An Outpatient Study of Automated Blood Glucose Control With an Insulin-Only Bionic Pancreas". This is an open-label, non-randomized, pilot study to determine the safety and feasibility of the insulin-only bionic pancreas.
What is the current status of trial NCT02536950?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2015-08. Estimated completion is 2016-07.
What interventions are being tested in trial NCT02536950?
The interventions under investigation include: Fixed set point (DEVICE), Variable set point (DEVICE).
Who is sponsoring clinical trial NCT02536950?
This trial is sponsored by Bruce A. Buckingham, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.